Primer probe combination and kit for detecting EGFR gene mutation
A technology of primer probes and kits, which is applied in the fields of biotechnology and tumor diagnosis, and can solve problems such as low sensitivity, time-consuming, and accuracy of small fragment deletions
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0112] The invention provides a method for detecting multiple gene mutations in lung cancer, primers, probes and a kit. The specific implementation steps are as follows:
[0113] (1) Extraction of nucleic acid templates from samples to be tested
[0114] Nucleic acid extraction or purification reagents from Sun Yat-Sen University Daan Gene Co., Ltd. (Tissue samples can use Yuesui Machinery Equipment No. 20170666; ascites and plasma samples can use Yuesui Machinery Equipment Number 20180628), and nucleic acid extraction is performed according to the kit instructions. The nucleic acid after tissue sample extraction is diluted to a concentration of 2-100ng / μL (the concentration of nucleic acid extracted from pleural fluid and plasma is not less than 2ng / μL), and the purity should meet A 260 / A 280 The ratio ranges between 1.7-2.3. The template can be used directly for subsequent experiments or stored at -80°C for future use, avoiding repeated freezing and thawing.
[0115] (2...
Embodiment 2
[0133] Embodiment 2 Sensitivity and accuracy detection
[0134] The sensitivity reference product with a nucleic acid concentration of 2ng / μL is composed of the detection gene locus plasmid DNA or cell line, and the wild-type cell line nucleic acid is mixed in a certain proportion, and the gene mutation rate of the mixture is 1%.
[0135] (1) Sample addition
[0136] Take 3 μL of the DNase system and add it to the PCR reaction tube. Centrifuge briefly for 15s.
[0137] Take 5 μL of negative quality control substance, sensitivity reference substance (with a concentration of 2 ng / μL mutation rate of 1%), and positive quality control substance, and add them to the reaction tube in sequence according to the order in Table 5. Close the cap of the PCR reaction tube tightly, mix well, and centrifuge briefly for 10s.
[0138] For each sensitivity reference product, 5 repeated experiments.
[0139] (2) Real-time fluorescent PCR amplification:
[0140] Set the real-time fluorescent...
Embodiment 3
[0148] Embodiment 3 clinical sample detection
[0149] Extraction of test sample nucleic acid:
[0150] (1) Extraction of nucleic acid templates from clinical samples to be tested
[0151] 100 negative clinical samples were collected, and 1 clinical sample of 18 EGFR gene exon 19 gene deletions confirmed by conventional methods was randomly mixed in after numbering, using nucleic acid extraction or purification reagents ( Tissue samples can use Yuesui Machinery No. 20170666; pleural fluid and plasma samples can use Yuesui Machinery No. 20180628), and nucleic acid extraction is carried out according to the kit instructions. The nucleic acid after tissue sample extraction is diluted to a concentration of 2-100ng / μL (chest The concentration of nucleic acid extracted from ascites and plasma should not be less than 2ng / μL), and the purity should meet A 260 / A 280 The ratio ranges between 1.7-2.3. The template can be used directly for subsequent experiments or stored at -80°C fo...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com